Results 201 to 210 of about 8,921 (241)

A Scoping Review of 5‐HT3 Antagonist Antiemetic Medication Safety in the Management of Nausea and Vomiting of Pregnancy

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 9, September 2026.
ABSTRACT Purpose The prescribing of 5‐hydroxytryptamine 3 receptor and type 3 serotonin receptor (5‐HT3) antagonists, particularly ondansetron, for nausea and vomiting in pregnancy (NVP) has increased globally. However, evidence on the safety of these medications in pregnancy remains unclear.
Shannon Morgan   +6 more
wiley   +1 more source

Prescription Medication Use During Pregnancy and Postpartum in Sweden 2007 to 2022

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 9, September 2026.
ABSTRACT Purpose Medication use during pregnancy has increased worldwide. The aim was to investigate patterns of prescription medication use during pregnancy and postpartum in Sweden 2007–2022. Methods We conducted a population‐based drug utilization study with linked data from the Swedish Medical Birth and Prescribed Drug Registers.
Essi Whaites Heinonen   +8 more
wiley   +1 more source

The role of serial blood tests during expectant management of early preeclampsia with severe features

open access: yesPregnancy, Volume 2, Issue 5, September 2026.
Abstract Background Expectant management of early‐onset preeclampsia with severe features (<34 weeks’ gestation) requires close maternal surveillance. Although serial testing is routinely performed, recommendations regarding testing frequency vary across professional societies and the clinical utility and financial impact of frequent testing during ...
Zakaria Doughan   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy